The $MRK 100c 4/17 calls have seen more than 3x return since being opened The position was actually rolled to a 110/120 ratio call spread, suggesting that the trader remains bullish on the name!

🦍 ApeXOmni 再度拓宽资产边界，新增 6 大美股永续合约，RWA 交易体验全面升级 ApeXOmni 在 RWA 股票永续赛道上的推进再次迎来关键一步。依托 Chainlink 提供的高可靠数据网络，ApeXOmni 的 RWA 股票永续产品矩阵正式扩容，新上线的 6 个美股核心标的，现在已全部支持 最高 50 倍杠杆，让链上交易者能够在更丰富的资产池中灵活构建策略。 本次新增的标的覆盖从医药到科技的核心蓝筹资产，包括： $MRK （Merck）：全球医药巨头，稳健基本面驱动长期价值。 $ABBV （AbbVie）：生物制药龙头，高分红与稳定现金流为其提供强劲底盘。 $MSFT （Microsoft）：AI 与云计算时代的核心资产。 $GOOGL （Google）：搜索、广告与 AI 多赛道布局的科技巨头。 $AMZN （Amazon）：全球电商与云服务的重要基石。 $AAPL （Apple）：消费电子与生态护城河最深的全球品牌之一。 至此，ApeXOmni 从最初的 5 个股票永续扩展到如今 11 个高流动性标的，产品覆盖度与策略弹性大幅提升，使交易者能够在链上获得更接近传统市场的资产配置自由度。 ApeXOmni 的 RWA 股票永续以传统金融的稳健资产作为锚点，再结合链上的高效率机制与永续结构，使用户能够以更低成本、更快执行速度参与全球市场。无论是构建跨板块策略、做对冲配置，还是捕捉科技与医药板块的短期高波动行情，ApeXOmni 都提供了更专业、更实用的工具套件。 此次升级也标志着 ApeXOmni 在 RWA 方向的持续进化：在真实资产的基础上叠加衍生品扩展空间，让交易者在链上即可布局全球资产格局，不再受地域、时区与账户体系的限制。 📈 立即体验美股永续合约交易： https://t.co/x64UGsZVzg 🔥 加入 ApeX，见证下一次成长： https://t.co/W28FbpMGO4 💬 了解更多项目信息： Discord: https://t.co/5c9557cvhH Telegram: https://t.co/Av7oh1nFDF #ApeX #ApeXOmni #Buyback #DeFi #KaitoAI @ApeXProtocolCN @OfficialApeXdex

Did you catch the $MRK 100c 4/17 flows from last week? 30,000+ volume, representing 27% of all MRK contracts traded on November 11th Contracts have ran from an average price of 3.10 to a high of 6.30 today https://t.co/8dWFuo6QgY Follow the flow today: https://t.co/3Tv3RKelFu

$MRK was a great example of how to use @unusual_whales 🐳 A large whale hit the calls around 3.10 and those contracts pushed to 4.85 for a 56.45 percent move. The flow, chain volume, and gamma all lined up which is exactly what you want to see when tracking a big entry. Full

Come checkout how traders use our tools, like how Flow God here found an unusual call buyer on $CDTX four days before the $MRK buyout news, resulting in a 3000% gain! Check us out at

Updated open interest data for all options contracts is now available across the Unusual Whales website. The $MRK 100c April flows, for example, are observing a decrease in open interest this morning. Given the volume on the 12th and the 13th being of similar size, it's highly likely that someone opened calls on the 12th and that same individual closed their contracts yesterday morning at the open. The larger player on the 11th is still holding their position. https://t.co/neXbC3sjOU

$MRK - MERCK SAYS INVESTING MORE THAN $70 BILLION TO EXPAND MANUFACTURING AND R&D IN U.S.

Another great opportunity for the stock portfolio: $MRK Much more defensive than my recent NVDA & MSFT buys - but I like this one just as much. Strong financials, stable growth, roughly 3% dividend & currently at a major discount. Bought some extra shares today.

QUICK MARKET SUMMARY: Consumer 🔸 Carvana ( $CVNA) upgraded to Overweight at Morgan Stanley; PT raised to $280 from $260. 🔸 Cintas ( $CTAS) ended talks to buy UniFirst (UNF) for $275/share. 🔸 KB Home ( $KBH) Q1 miss: revenue down 5%, net income down 21%, lowers FY25 outlook; appoints Robert Dillard as CFO. 🔸 McCormick ( $MKC) Q1 EPS $0.60 (vs. $0.64 est.), reaffirms FY25 guidance. 🔸 Smithfield Foods sees higher annual sales and profit. 🔸 Tesla ( $TSLA) European market share down sharply; YTD sales -42.6%. Energy, Industrials & Materials 🔸 American Electric ( $AEP) announces $2B stock offering. 🔸 Bunge ( $BG) selling European margarine business to Vandemoortele. 🔸 Canadian Solar ( $CSIQ) Q4 EPS loss (-$1.47) vs. (-$0.24) est.; record storage shipments. 🔸 Enerpac ( $EPAC) Q2 EPS $0.38 (vs. $0.40 est.), maintains guidance. 🔸 EOG Resources ( $EOG) downgraded to Neutral at Mizuho; PT cut to $140. 🔸 Oklo ( $OKLO) FY24 EPS loss (-$0.74); first Aurora deployment expected late 2027. 🔸 Parsons ( $PSN) approves $250M share buyback. 🔸 TechnipFMC ( $FTI) wins $500M–$1B EPC contract from Equinor. Healthcare 🔸 Aura Biosciences ( $AURA) FY loss ($96M); cash runway into 2H26. 🔸 Beyond Air ( $XAIR) secures $2M for autism therapy development. 🔸 Merck ( $MRK) signs $200M licensing deal for Lp(a) inhibitor, potential $1.77B in milestones. 🔸 Neurogene ( $NGNE) FY loss ($82.6M); files $300M shelf offering; cash runway into 2H27. Tech, Media & Telecom 🔸 Alibaba ( $BABA) to restart hiring; Chairman Tsai warns of potential AI bubble. 🔸 Cloudflare ( $NET) double-upgraded to Buy at BofA; PT raised to $160. 🔸 India plans to scrap 6% digital ad tax, easing pressure on U.S. tech firms. 🔸 Crown Castle ( $CCI) appoints interim CEO Daniel Schlanger; reaffirms guidance. 🔸 Volkswagen ( $cVOWGY) partners with Valeo and Mobileye for advanced driver-assistance systems.

MORNING BID 🔸 OpenAI: Plans to reduce reliance on NVIDIA ( $NVDA) by developing its first in-house AI chip, with design finalization in the next few months. Chips will be manufactured by Taiwan Semiconductor ( $TSM) 🔸 ChipMOS Technologies ( $IMOS): Expects 6.3% revenue growth for 2024, despite a 5.4% YoY decline in Dec 2024 and 5.7% YoY decline in Q4 2024. Plans to buy back shares up to T$17.39B. 🔸 Mobileye ( $MBLY): Upgraded to Neutral by Bank of America, citing limited downside risk and bottoming sentiment. 🔸 Taiwan Semiconductor ( $TSM): Q1 revenue expected at the lower end of guidance due to a $161M (NT$5.3B, net of insurance) impact from a late January earthquake in southern Taiwan. 🔸 Edgewell Personal Care ( $EPC): Q1 adj. EPS $0.07 (est. $0.12); Q1 revs $478.4M (est. $480.16M). FY25 outlook: adj. EPS at lower end of $3.15-$3.35 (est. $3.18), adj. EBITDA at lower end of $356M-$368M, capex 2.5%-3% of revenue. 🔸 Rivian ( $RIVN): Now selling delivery vans to fleets of all sizes in the US, over a year after ending exclusivity with Amazon ( $AMZN). 🔸 Sun Country Airlines ( $SNCY): Announces secondary offering of 6.3M shares and $10M share repurchase from underwriters. 🔸 Illumina ( $ILMN): Downgraded to Underweight from Equal Weight by Barclays. 🔸 Merck ( $MRK): Downgraded to Hold from Buy by TD Cowen, price target cut to $100 from $121. 🔸 Pliant Therapeutics ( $PLRX): Shares fall as it pauses enrollment and dosing in the ongoing Beacon-IPF Phase 2b trial of bexotegrast for idiopathic pulmonary fibrosis. 🔸 BP Plc ( $BP): Shares rise after Elliott Management takes a stake, expected to push for strategy and board changes. 🔸 ConocoPhillips ( $COP): Downgraded to Outperform from Strong Buy by Raymond James. 🔸 Spirit AeroSystems ( $SPR): Q4 2024 net revenues $1.66B (down from $1.81B YoY, above est. $1.53B); reported $401M in net forward loss charges. 🔸 US Metals Stocks: Shares of Cleveland Cliffs ( $CLF), Nucor ( $NUE), Alcoa ( $AA), and others rise after Trump announces 25% steel and aluminum tariffs in latest trade escalation.

#Upgrades - Dec 04, 2024 • $BRKL: KBW Upgrades to Outperform from Market Perform • $MAC: Mizuho Upgrades to Neutral from Underperform - PT $22 (from $14) • $MRK: HSBC Upgrades to Buy from Hold - PT $130 • $NFE: Deutsche Bank Upgrades to Hold from Sell - PT $11 (from $7.60) • $PNW: KeyBanc Upgrades to Overweight from Sector Weight - PT $101 • $PSTG: Piper Sandler Upgrades to Overweight from Neutral - PT $76 (from $56) • $SHBI: KBW Upgrades to Outperform from Market Perform • $TRMB: JPMorgan Upgrades to Overweight from Neutral - PT $92 (from $74)

#Downgrades - Nov 11, 2024 • $AGL: JMP Securities Downgrades to Market Perform from Market Outperform • $ALTM: Scotiabank Downgrades to Sector Perform from Sector Outperform - PT $5.85 • $ARDX: H.C. Wainwright Downgrades to Neutral from Buy - PT $5.50 • $ATMU: Wells Fargo Downgrades to Equal Weight from Overweight - PT $45 (from $42) • $BLMN: Raymond James Downgrades to Market Perform from Outperform • $CBT: JPMorgan Downgrades to Underweight from Neutral - PT $105 • $CE: BMO Capital Downgrades to Underperform from Market Perform - PT $76 (from $138) • $CE: UBS Downgrades to Neutral from Buy - PT $97 (from $161) • $GCMG: TD Cowen Downgrades to Hold from Buy - PT $15.50 • $IMCR: Mizuho Downgrades to Neutral from Outperform - PT $38 (from $72) • $MRK: Daiwa Securities Downgrades to Neutral from Outperform • $NOV: Citi Downgrades to Neutral from Buy - PT $18 (from $21) • $NRDY: JPMorgan Downgrades to Underweight from Neutral • $NVR: Seaport Global Securities Downgrades to Neutral from Buy • $PRA: Piper Sandler Downgrades to Neutral from Overweight - PT $18 • $RVTY: Nephron Downgrades to Sell from Sell - PT $105 • $SMAR: Guggenheim Downgrades to Neutral from Buy • $TDW: Raymond James Downgrades to Outperform from Strong Buy - PT $102 (from $131) • $TEM: Stifel Downgrades to Hold from Buy - PT $65 (from $45) • $VALE: UBS Downgrades to Neutral from Buy - PT $11.50 (from $14) • $WHF: Oppenheimer Downgrades to Perform from Outperform - PT $12 (from $14) • $XERS: Piper Sandler Downgrades to Neutral from Overweight - PT $3